Peripheral Vascular
User group meetings masthead

See clearly.

Treat optimally.

Angio alone image

IVUS in Endovascular Procedures

A practical overview highlighting the value of IVUS in venous, aortic and PAD procedures.

Angio alone image

Angiography alone is

not enough

Angiography provides information on luminal characteristics of peripheral arteries, but severely underestimates the extent of atherosclerosis in patients with PAD, even in “normal appearing” vessels.1

Visualize the best path forward with IVUS eyes

Philips IVUS provides the visualization needed to gain deeper insights into the lesion and choose the best procedural path forward.

One icon


Two icon

Eccentric fibrotic plaque with deep calcium nodule

Three icon

Accoustic shadowing

Vessel size

Guides device sizing to ensure precise wall apposition, drug delivery, and placement

Vessel diameter

Vessel diameter

Lumen diameter

Lumen diameter

Plaque burden

Plaque burden

Plaque morphology

Understand plaque type and severity to help guide proper device selection

Soft image


Fibrous image


Calcific image


Thrombus image


CTO image


Plaque geometry

Visualize plaque burden location for precise treatment

Concentric image


Eccentric image


Guidewire position

Confirm true lumen or sub-intimal guidewire location

True lumen

True lumen

Sub intimal


Take the IVUS Challenge

user group meetings

Treat optimally with versatility

The Philips portfolio of therapeutic devices offers the versatility needed to treat the majority of PAD cases, including complex lesions. 

IVUS image interpretation for PAD intervention

Dr Michael Lichtenberg and Dr Konstantinos Stavroulakis discuss the basics of IVUS image interpretation for PAD intervention. Using case- based examples, they demonstrate the added value of IVUS to assess the architecture and pathology of diseased arteries and how this additional information may influence treatment strategy and improve patient outcomes

video thumbnail image

Dr Lichtenberg and Dr Stavroulakis discuss the IVUS technical characteristics and the rationale for using IVUS to complement angiography in PAD intervention

video thumbnail image

Using case based examples, Dr Stavroulakis discusses the four pillars of IVUS, a framework that demonstrates the added value IVUS brings to angiography

video thumbnail image

Dr Stavroulakis demonstrates the use of IVUS to understand calcium geometry and morphology and how this may influence treatment strategy.

video thumbnail image

Dr Lichtenberg demonstrates the ability of IVUS to reveal the depth, circumference and free lumen area resulting from dissection and how this may impact treatment strategy.

video thumbnail image

Dr Stavroulakis discusses how angiography can often underestimate severity of PAD, and how IVUS can accurately measure and quantify percent stenosis and plaque burden.

video thumbnail image

Dr Lichtenberg demonstrates the sensitivity of IVUS to detect and differentiate between chronic and acute thrombus, and how this information informs treatment strategy.

Introducing Tack Endovascular system

The Tack endovascular system is an adjunct therapy to balloon angioplasty, purpose-built for precision dissection repair to promote healing, improve outcomes and preserve limbs.

Discover Tack


Atherectomy for small arteries*
Introducing Phoenix 1.5 atherectomy catheter

Adding a dedicated below the knee solution to comprehensive Phoenix portfolio

Small 4F profile for treatment below the ankle* and channel creation in tight calcified lesions often seen in CLI patients.

High efficiency with our most advanced cutterhead technology9,10

Phoenix - Safe, simple and effective. 3

phoenix family bubble
cutterhead bubble
4f bubble bubble icon

Treat safely and effectively5,6,7,8,14,15
with low-dose Philips Stellarex drug-coated balloon


Available in lengths up to 200mm

stellarex bubble
Doctor checking the data

Full view treatment planning


The integration of visualization and interventional technologies allows physicians to see the complete picture and create a more informed and individualized procedural approach.

Treatment plan example 1

Treatment plan example 2

Treatment plan example 1

Treatment plan example one
One icon


Two icon

Eccentric fibrotic plaque with deep calcium nodule

Three icon

Acoustic shadowing

Treatment plan example 2

Treatment plan example two
One icon

Lumen with fresh thrombus

Two icon


Three icon

Calcified plaque with acoustic shadowing

See clearly

Vessel size: 5.5 mm diameter

Plaque morphology: Fibrotic plaque with intimal and medial calcium

Plaque geometry: Eccentric lesion

Guidewire position: True lumen

Vessel size: 6 mm diameter

Plaque morphology: Mixed, thrombic plaque with medial calcium

Plaque geometry: Eccentric lesion

Guidewire position: True lumen

Treat optimally

Quick-Cross catheter: Confidently cross challenging morphologies

Phoenix deflecting atherectomy: Front facing to cut, capture and clear mixed morphologies, including calcium; deflecting capabilities for larger luminal gain

AngioSculpt scoring balloon: Score calcium to reduce dissection4

Stellarex DCB: Designed for performance in calcium

Quick-Cross catheter: Confidently cross challenging morphologies

Turbo-Power laser atherectomy: Forward facing directional debulking to clear thrombus; rotation for improved deliverability in calcified lesions

AngioSculpt scoring balloon: Safely dilate residual stenosis4

Stellarex DCB: Designed for performance in calcium

1. Kashyap VS. Pavkov ML, Bishop PD, et al. Angiography underestimates peripheral atherosclerosis: lumenography revisited. J Endovasc Ther. 2008;15(1): 117-125.

2. Dippel et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):92-101

3. Davis, Thomas et al., Safety and effectiveness of the Phoenix Atherectomy System in lower extremity arteries: Early and midterm outcomes from the prospective multicenter EASE study. Vascular. September 27, 2017, DOI: 10.1177/1708538117712383.  

4. Kiesz RS, Scheinert D, Peeters PJ, et al. Results from the international registry of the AngioSculpt Scoring Balloon Catheter. J Am Coll Cardiol. 2008;51:10(suppl B);75.

5. Brodmann M, Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon The ILLUMENATE European Randomized Clinical Trial 2-Year Results, J Am Coll Cardiol Intv 2018;11:2357–64. Dec 2018

6. Mathews J. NCVH, 2019. Stellarex in the Treatment of the SFA and Popliteal: Late-Breaking 3-Year Data. May 29, 2109 New Orleans, LA.

7. Brodmann M, Final Long-Term Mortality Results of Paclitaxel-Coated DCBs from the ILLUMENATE RCTs: 5-Year Data from EU RCT and Pivotal studies, oral presentation, virtual LINC, Jan 2021

8. Lyden S, Long-Term Safety of Stellarex DCB Across ILLUMENATE RCTs, oral presentation, virtual VIVA 2020, Nov 2020

9. Based on bench tests. Data on file at Philips.

10. Compared to previous generation cutter head Phoenix atherectomy system catheters. Bench test data on file at Philips.

Performance in bench tests is not indicative of the behavior in clinical practice.
11. Gagne PG, TaharaRW, FastabendCP,etal. Venography versus intravascular ultrasound for diagnosing and treating iliofemoral vein obstruction. J VascSurg:Venousand LymDis 2017;5:678-87.

12. N=15 Data on File at Volcano Corporation. Windchill Report #209-0205.08

13. PliagasG, Saab F, StavroulakisK, et al. Intravascular Ultrasound Imaging Versus Digital Subtraction Angiography in Patients with Peripheral Vascular Disease. J Invasive Cardiol. 2020 Mar;32(3):99-103

14. Gray W,  Long-Term Safety of Stellarex DCB Across ILLUMENATE RCTs: 5-year results from a patient-level meta-analysis of the ILLUMENATE RCTs, oral presentation, Charing Cross Virtual Edition, Apr 2021

15. Brodmann M, Wissgott C, Brechtel K, et al. Optimized drug-coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: TOBA III 12-month results. J Vasc Surg. 2020;S0741-5214(20)30330-X.

16. Geraghty PJ, Adams GL, Schmidt A, Lichtenberg M, Wissgott C, Armstrong EJ, Hertting K, on behalf of the TOBA II BTK Investigators. Twelve-month results of Tack-optimized balloon angioplasty using the Tack Endovascular System in below-the-knee arteries (TOBA II BTK). Journal of Endovascular Therapy 27.4 (2020): 626-636.


Refer to product labeling for complete indications, contraindications, and warnings.

Product subject to country availability. Please contact your local sales representative


*Minimum vessel size 2.0mm, see IFU.

©2021 Koninklijke Philips N.V. All rights reserved.


We are always interested in engaging with you.

Let us know how we can help.

Select your area of interest
Contact details

You are about to visit a Philips global content page


You are about to visit a Philips global content page


Vår webbplats visas bäst i senaste versionen av Microsoft Edge, Google Chrome eller Firefox.